Portfolio
Latest Articles
Weekenders
Quick Takes
Education
Trust

Email

Are you a s708 sophisticated investor? Check this box if you are interested in s708 only investment offers.

I consent to the processing of my personal data in accordance with the Privacy Policy

Portfolio
Latest Articles
Weekenders
Quick Takes
Education
Trust

Home
ASX:TLX

ASX:TLX

Telix Pharmaceuticals Limited

ASX:TLX

- Telix Pharmaceuticals Limited

INVESTMENT MEMO

MEMO
ARTICLES
QUICK TAKES
WEEKEND MENTIONS
SUMMARY

There is no investment memo published for this company

Footer

Portfolio

Support

Contact Us
Trust Centre
How it Works
History
FAQ
Definitions
Archived Articles
Bottom Drawer Portfolio

Policies

Customer Notice
Disclosure Policy
Financial Services Guide
ESG Policy
Privacy Policy

Subscribe Next Investors

Daily write ups on small cap stocks we are invested in:

Email

I consent to the processing of my personal data in accordance with the Privacy Policy

This material has been prepared by S3 Consortium Pty Ltd (trading as StocksDigital). S3 Consortium Pty Ltd is a Corporate Authorised Representative (CAR 000433913) of 62 Consulting Pty Limited (ABN 88 664 809 303) (AFSL 548573) (62C).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by 62C, Price, StocksDigital, any of their related body corporates or any other person. To the maximum extent possible, 62C, Price, StocksDigital, their related body corporates or any other person do not accept any liability for any statement in this material.

© 2026 nextinvestors.com | All rights reserved

Follow Us